(Q43508717)

24 November 2017

0 references

Can we afford to ignore missing data in cost-effectiveness analyses? (English)

1 reference

24 November 2017

1 reference

Lucinda J. Billingham

series ordinal

2

1 reference

24 November 2017

Andrea Marshall

1

1 reference

24 November 2017

Stirling Bryan

series ordinal

3

1 reference

24 November 2017

publication date

1 February 2009

1 reference

The European Journal of Health Economics

24 November 2017

published in

1 reference

24 November 2017

volume

10

1 reference

24 November 2017

issue

1

1 reference

24 November 2017

page(s)

1-3

1 reference

https://scigraph.springernature.com/pub.10.1007/s10198-008-0129-y

24 November 2017

exact match

0 references

cites work

Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10198-008-0129-Y

EUROCARE-3: survival of cancer patients diagnosed 1990-94--results and commentary.

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18936993

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Estimates of the cancer incidence and mortality in Europe in 2006.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18936993

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18936993

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S10198-008-0129-Y

1 reference

24 November 2017

1 reference